Market Value2,160,261,525
Total Holdings55
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NUVB / Nuvation Bio Inc.
MORF / Morphic Holding, Inc.
HRTX / Heron Therapeutics, Inc.
NKTX / Nkarta, Inc.
IMGN / ImmunoGen, Inc. Put
JNCE / Jounce Therapeutics Inc
EXEL / Exelixis, Inc.
ANIP / ANI Pharmaceuticals, Inc.
/ STRUCTURE THERAPEUTICS INC 0.00000000
RAPT / RAPT Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
FDMT / 4D Molecular Therapeutics, Inc.
ETNB / 89bio, Inc.
IMUX / Immunic, Inc.
NTLA / Intellia Therapeutics, Inc.
SLNCF / Silence Therapeutics plc
AXSM / Axsome Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock) Put
PRTA / Prothena Corporation plc Put
FGEN / FibroGen, Inc. Call
ALLK / Allakos Inc.
ITCI / Intra-Cellular Therapies, Inc.
SGEN / Seagen Inc Put
DCPH / Deciphera Pharmaceuticals, Inc.
GHRS / GH Research PLC
ACRS / Aclaris Therapeutics, Inc.
VIGL / Vigil Neuroscience, Inc.
RLMD / Relmada Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
ZURA / Zura Bio Limited
ISEE / IVERIC bio Inc
VRDN / Viridian Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
INKT / MiNK Therapeutics, Inc.
DYNE / Dyntek Inc
IPSC / Century Therapeutics, Inc.
EDIT / Editas Medicine, Inc.
IMVT / Immunovant, Inc.
GH / Guardant Health, Inc.
PNT / POINT Biopharma Global Inc.
TSVT / 2seventy bio, Inc.
GERN / Geron Corporation
QURE / uniQure N.V.
KDNY / Chinook Therapeutics Inc
ALKS / Alkermes plc
BIIB / Biogen Inc.
PACB / Pacific Biosciences of California, Inc.
RPTX / Repare Therapeutics Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
MLTX / MoonLake Immunotherapeutics
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
EWTX / Edgewise Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
IONS / Ionis Pharmaceuticals, Inc.
INZY / Inozyme Pharma, Inc.
BEAM / Beam Therapeutics Inc.
JAZZ / Jazz Pharmaceuticals plc
TVTX / Travere Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ETNB / 89bio, Inc. Put
NRIX / Nurix Therapeutics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
PLRX / Pliant Therapeutics, Inc.
DICE / DICE Therapeutics Inc
AGEN / Agenus Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NKTR / Nektar Therapeutics
TERN / Terns Pharmaceuticals, Inc.